Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy

Despite the availability of molecularly targeted agents for advanced hepatocellular carcinoma (aHCC), these are limited to compensated cirrhotic patients, and concerns about decreased hepatic functional reserve (HFR) and unknown adverse events, which may affect long-term survival, remain unaddressed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Moriya, Kei, Namisaki, Tadashi, Takaya, Hiroaki, Kaji, Kosuke, Kawaratani, Hideto, Shimozato, Naotaka, Sawada, Yasuhiko, Douhara, Akitoshi, Sato, Shinya, Furukawa, Masanori, Kitagawa, Koh, Akahane, Takemi, Yoshiji, Hitoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914951/
https://ncbi.nlm.nih.gov/pubmed/33562238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040629
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky